Model DetailsOviduct hyperplasia
Model Name |
Oviduct hyperplasia | Strain |
CD-1 |
Tumor Inducing Agent(s) |
Chemical/Drug : tamoxifen (TAM) |
Tumor Synonyms |
oviduct hyperplasia • progressive proliferative lesion of the oviduct (PPL) |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Oviduct | Female |
100% (17 of 17 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
93% (14 of 15 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
100% (9 of 9 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
100% (11 of 11 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
100% (11 of 11 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |
| Oviduct | Female |
100% (10 of 10 mice) |
14-17 months |
|
Newbold RR, Carcinogenesis 1997 Dec;18(12):2293-8 |